Invention Grant
- Patent Title: Serum albumin binding molecules
- Patent Title (中): 血清白蛋白结合分子
-
Application No.: US14552823Application Date: 2014-11-25
-
Publication No.: US09540424B2Publication Date: 2017-01-10
- Inventor: Michael L. Gosselin , David Fabrizio , Joanna F. Swain , Tracy Mitchell , Ray Camphausen , Sharon T. Cload , Eric Furfine , Paul E. Morin , Ranjan Mukerjee , Simeon I. Taylor
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/435 ; A61K47/48 ; C07K14/78 ; C12N15/62 ; C07K14/50 ; C07K14/575
Abstract:
The present invention relates to an antibody-like protein based on the tenth fibronectin type III domain (10Fn3) that binds to serum albumin. The invention further relates to fusion molecules comprising a serum albumin-binding 10Fn3 joined to a heterologous protein for use in diagnostic and therapeutic applications.
Public/Granted literature
- US20150152147A1 SERUM ALBUMIN BINDING MOLECULES Public/Granted day:2015-06-04
Information query
IPC分类:
